Literature DB >> 17906803

An overview of Chagas disease treatment.

Jean Jannin1, Luis Villa.   

Abstract

Chagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Through national programmes and multinational initiatives coordinated by WHO-PAHO, much has been accomplished in these domains in terms of reducing transmission. Attention now turns to consolidating the successes in interrupting transmission, and improved treatment for those already infected and those who may become affected in the future. This article, based on technical discussions at the "Epidemiological and Sociological Determinants of Chagas Disease, Basic Information to Establish a Surveillance and Control Policy " meeting in Rio de Janeiro, is designed to open the debate on appropriate strategies for continuation of the successful initiatives against Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906803     DOI: 10.1590/s0074-02762007005000106

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  26 in total

1.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

2.  Expression, purification, and biochemical characterization of recombinant DNA polymerase beta of the Trypanosoma cruzi TcI lineage: requirement of additional factors and detection of phosphorylation of the native form.

Authors:  Edio Maldonado; Diego A Rojas; Sandra Moreira-Ramos; Fabiola Urbina; Vicente J Miralles; Aldo Solari; Juan Venegas
Journal:  Parasitol Res       Date:  2015-01-09       Impact factor: 2.289

3.  Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones.

Authors:  Viviane Rodrigues Esperandim; Daniele da Silva Ferreira; Juliana Saraiva; Márcio Luis Andrade Silva; Eveline Soares Costa; Ana Carolina Pereira; Jairo Kenupp Bastos; Sérgio de Albuquerque
Journal:  Parasitol Res       Date:  2010-05-04       Impact factor: 2.289

4.  Trypanocidal activity and acute toxicity assessment of triterpene acids.

Authors:  Daniele da Silva Ferreira; Viviane Rodrigues Esperandim; Miriam Paula Alonso Toldo; Juliana Saraiva; Wilson Roberto Cunha; Sérgio de Albuquerque
Journal:  Parasitol Res       Date:  2010-02-06       Impact factor: 2.289

5.  In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi.

Authors:  K Salomão; E M de Souza; S A Carvalho; E F da Silva; C A M Fraga; H S Barbosa; S L de Castro
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

6.  Evaluating 5-nitrofurans as trypanocidal agents.

Authors:  Christopher Bot; Belinda S Hall; Guzmán Alvarez; Rossanna Di Maio; Mercedes González; Hugo Cerecetto; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2013-01-18       Impact factor: 5.191

7.  Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.

Authors:  Mariana C Waghabi; Elen M de Souza; Gabriel M de Oliveira; Michelle Keramidas; Jean-Jacques Feige; Tania C Araújo-Jorge; Sabine Bailly
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

8.  Pregnancy and Chagas Disease: Benznidazole's Impact on Pregnancy and Newborns: A Report of Four Cases.

Authors:  Cristina Vázquez; Elisa García-Vázquez; Bartolomé Carrilero; Marina Simón; Fuensanta Franco; Maria A Iborra; Luis J Gil-Gallardo; Manuel Segovia
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

9.  Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies.

Authors:  María Elena Marsón; Diego Dante Dana; Jaime Altcheh; Facundo García-Bournissen; Guido Mastrantonio
Journal:  J Clin Lab Anal       Date:  2013-09       Impact factor: 2.352

10.  A versatile qPCR assay to quantify trypanosomatidic infections of host cells and tissues.

Authors:  Eugenia Bifeld; Paloma Tejera Nevado; Janika Bartsch; Julia Eick; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2016-06-09       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.